Red X iconGreen tick iconYellow tick icon
The University of Otago has launched a new brand. Find out more

Contact Details

Email
aline.boer@otago.ac.nz
Position
Research Fellow
Research summary
Research into the central role of glucose-dependent insulinotropic polypeptide (GIP) in the regulation of body weight
Memberships
Publicity and Events Committee

Publications

Pretz, D., Heyward, P. M., Krebs, J., Gruchot, J., Barter, C., Silcock, P., Downes, N., Rizwan, M. Z., Boucsein, A., Bender, J., Burgess, E. J., Boer, G. A., Keerthisinghe, P., Perry, N. B., & Tups, A. (2023). A dahlia flower extract has anti-diabetic properties by improving insulin function in the brain. Life Metabolism, 2(4), load026. doi: 10.1093/lifemeta/load026 Journal - Research Article

Boer, G. A., Hay, D. L., & Tups, A. (2022). Obesity pharmacotherapy: Incretin action in the central nervous system [Review]. Trends in Pharmacological Sciences, 44(1), 50-63. doi: 10.1016/j.tips.2022.11.001 Journal - Research Article

Gabe, M. B. N., Skov-Jeppesen, K., Gasbjerg, L. S., Schiellerup, S. P., Martinussen, C., Gadgaard, S., Boer, G. A., … Rosenkilde, M. M. (2022). GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment. Pharmacological Research, 176, 106058. doi: 10.1016/j.phrs.2022.106058 Journal - Research Article

Gadgaard, S., van der Velden, W. J. C., Schiellerup, S. P., Hunt, J. E., Gabe, M. B. N., Windeløv, J. A., Boer, G. A., … Rosenkilde, M. M. (2022). Novel agonist- and antagonist-based radioligands for the GLP-2 receptor: Useful tools for studies of basic GLP-2R pharmacology. British Journal of Pharmacology, 179, 1998-2015. doi: 10.1111/bph.15766 Journal - Research Article

Boer, G. A., Hartmann, B., & Holst, J. J. (2021). Pharmacokinetics of exogenous GIP(1-42) in C57Bl/6 mice: Extremely rapid degradation but marked variation between available assays. Peptides, 136, 170457. doi: 10.1016/j.peptides.2020.170457 Journal - Research Article

Back to top